Bluing Reagent
- High-quality products
- Superior customer service
- 30-day money back guarantee
Product Information
Bluing Reagent may be used following hematoxylin to "blue" or alter the shade of hematoxylin from a purple to blue. Nuclei: Purple. Nuclei after Bluing: Blue. Blue nuclei after Eosin: Blue to Violet. A pH-controlled solution for complete and effective bluing of hematoxylin in histological and cytological procedures. Hematoxylin is a nuclear stain that is used as a counterstain for immunohistochemistry. Together with eosin, it forms the hematoxylin stain (H&E stain), one of the most commonly used stains in histology.
Summary Protocol:
Stain with hematoxylin according to protocol. Place in Bluing Reagent until nuclei are blue (1-2 minutes).
Literary References
Hanwright PJ, Rath JB, von Guionneau N, Slavin B, Pinni S, Zlotolow D, Shores J, Dellon AL, Tuffaha SH. The effects of a porcine extracellular matrix nerve wrap as an adjunct to primary epineurial repair. The Journal of Hand Surgery. 2021 Sep 1;46(9):813-e1.
Jacobs SO, Sheller‐Miller S, Richardson LS, Urrabaz‐Garza R, Radnaa E, Menon R. Characterizing the immune cell population in the human fetal membrane. American Journal of Reproductive Immunology. 2021 May;85(5):e13368.
Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients. 2019 Mar;11(3):599.
Bellon M, Moles R, Chaib-Mezrag H, Pancewicz J, Nicot C. JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells. Journal of Hematology & Oncology. 2018 Dec;11(1):1-2.
Nandi SS, Shahshahan HR, Shang Q, Kutty S, Boska M, Mishra PK. MiR-133a mimic alleviates T1DM-induced systolic dysfunction in Akita: an MRI-based study. Frontiers in physiology. 2018 Oct 10;9:1275.
Jung SH, Song HY, Hyun YS, Kim YC, Whang I, Choi TY, Jo S. A brain atlas of the long arm octopus, octopus minor. Experimental neurobiology. 2018 Aug;27(4):257.
Bellon M, Lu L, Nicot C. Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia. Blood, The Journal of the American Society of Hematology. 2016 May 19;127(20):2439-50.
